Evidence map›Paper›PMID 35765946›Full record

ArticleBiomolecules & biomedicine2023

Evaluation of TyG index and TG/HDL-C ratio in HBeAg negative chronic hepatitis B infected patients.

Tülay Ünver Ulusoy, Heval Can Bilek, Hacer Demirköse, Ayşegül Keleş

Open access · diamondAbstract read
In one paragraph

Article in Biomolecules & biomedicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Tülay Ünver UlusoyUniversity of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Infectious Diseases and Clinical Microbiology, Ankara, Turkey.
Heval Can BilekOndokuz Mayıs University Faculty of Medicine, Infectious Diseases and Clinical Microbiology, Samsun, Turkey.
Hacer DemirkösePursaklar District Health Directorate, Public Health, Ankara, Turkey.
Ayşegül KeleşYıldırım Beyazıt University Yenimahalle Training and Research Hospital, Biochemistry, Ankara, Turkey.
Ankara Yıldırım Beyazıt University · TROndokuz Mayıs University · TRSağlık Bilimleri Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with hepatitis B e antigen (HBeAg) negative chronic HBV infection are regularly followed up. This study investigates the presence of insulin resistance and the relationship between hepatosteatosis and insulin resistance in patients with HBeAg negative chronic HBV infection using the TyG index and TG/HDL-C ratio. Patients with HBeAg negative chronic HBV infection who applied to the Infectious Diseases and Clinical Microbiology outpatient clinic between January 2019 and December 2020 were included in the study. Glucose, lipid panel, alanine amino transferase (ALT), acetyl amino transferase (AST), body mass index (BMI), TyG index, TG/HDL-C and hepatobiliary ultrasonography (USG) results were evaluated. The data were compared with the control group consisting of 308 HBsAg negative individuals. The study included 132 patients with a median age of 52 years. There was no significant difference between the patient and control groups regarding age, gender and BMI. Glucose, total cholesterol, TG, LDL, AST, ALT, TyG index and TG/HDL-C ratio were significantly higher in patient than in the control group. At the same time, the HDL value was significantly lower in the patients. There was a strong positive correlation between the TG and BMI, and a strong negative correlation between HDL levels and both TyG index and TG/HDL-C ratio. Our findings showed that the TyG index and TG/HDL-C ratio are helpful in the diagnosis of insulin resistance and hepatosteatosis in patients with HBeAg negative chronic HBV infection.

Indexed as

D-Alanine TransaminaseHepatitis B, ChronicInsulin ResistanceAlanine TransaminaseBody Mass IndexGlucoseHepatitis B e AntigensHumansMiddle AgedAlanine TransaminaseD-Alanine TransaminaseGlucoseHepatitis B e Antigens

Identifiers

PMID35765946
PMCPMC9901891
OpenAlexW4283690032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.